Acute lymphoblastic leukaemia study day

This study day is being organised by Amgen.
Elaine will deliver the morning session, covering:

Part 1:
The cellular and genetic make-up of acute lymphoblastic leukaemia (ALL)
• A bit about B cells
• Genetic drivers of ALL
• Clonal evolution & intratumoural heterogeneity
• The role of leukaemic stem cells

Treating Philadelphia Chromosome Positive ALL
• Bcr-Abl inhibitors
• Other treatments

Part 2:
Licensed and novel treatments for ALL
• Blinatumumab
• Inotuzumab ozogamicin
• CAR-modified T cells
• Other treatments in trials

Contact Elaine if you would like to know how to book a place.

View the programme

I really enjoyed the day and found your teaching style excellent. Science communication is no easy skill.
I returned to the office full of enthusiasm and actually refreshed!

Macmillan Nurse Leeds

The "Science Pick-n-Mix" presentation was particularly timely, being the first day of the conference, in de-mystifying some of the medical jargon - especially for me as a patient participant!
I have just completed the conference feedback survey and identified your presentation as being one the most useful of the conference.

Patient representative attending the NCRI conference Liverpool

Elaine's training day was delivered with focus, passion and engagement.
It helped the Roche Oncology MSL team and Medical Affairs colleagues alike to significantly improve their baseline knowledge around the molecular mechanisms involved in cancer and the targeted treatments

Medical Scientific Liaison Team, Roche